(Q35956310)

11 August 2017

1 reference

title

Erythropoietin: novel approaches to neuroprotection in human brain disease (English)

1 reference

11 August 2017

1 reference

1

Hannelore Ehrenreich

0 references

Manfred Herrmann

object named as

Manfred Herrmann

6

0 references

Anna-Leena Sirén

object named as

Anna-Leena Sirén

7

0 references

author name string

Carlotta Aust

2

1 reference

11 August 2017

Henning Krampe

3

1 reference

11 August 2017

Henriette Jahn

4

1 reference

11 August 2017

Sonja Jacob

5

1 reference

11 August 2017

1 December 2004

1 reference

11 August 2017

Metabolic Brain Disease

1 reference

11 August 2017

19

1 reference

11 August 2017

3-4

1 reference

11 August 2017

195-206

1 reference

https://scigraph.springernature.com/pub.10.1023/b:mebr.0000043969.96895.3c

11 August 2017

0 references

cites work

Adult neurogenesis: a compensatory mechanism for neuronal damage

1 reference

12 December 2020

Erythropoietin and retinoic acid, secreted from the epicardium, are required for cardiac myocyte proliferation

1 reference

12 December 2020

Brain derived proteins as markers of acute stroke: their relation to pathophysiology, outcome prediction and neuroprotective drug monitoring.

1 reference

12 December 2020

Propentofylline in the treatment of vascular dementia and Alzheimer-type dementia: overview of phase I and phase II clinical trials.

1 reference

12 December 2020

Erythropoietin restores glutathione peroxidase activity in 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine-induced neurotoxicity in C57BL mice and stimulates murine astroglial glutathione peroxidase production in vitro

1 reference

12 December 2020

To model a psychiatric disorder in animals: schizophrenia as a reality test

1 reference

12 December 2020

Erythropoietin exerts neuroprotective effect in neonatal rat model of hypoxic-ischemic brain injury.

1 reference

12 December 2020

Functional erythropoietin receptor of the cells with neural characteristics. Comparison with receptor properties of erythroid cells

1 reference

12 December 2020

Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators.

1 reference

12 December 2020

Expression patterns of erythropoietin and its receptor in the developing midbrain

1 reference

12 December 2020

Schizophrenia as a disorder of neurodevelopment

1 reference

12 December 2020

Pleiotropic functions and tissue-specific expression of erythropoietin

1 reference

12 December 2020

Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress

1 reference

12 December 2020

Erythropoietin gene expression in human, monkey and murine brain.

1 reference

12 December 2020

Protective effect of erythropoietin on the oxidative damage of erythrocyte membrane by hydroxyl radical

1 reference

12 December 2020

Is schizophrenia a neurodegenerative disorder? A clinical and neurobiological perspective

1 reference

12 December 2020

Schizophrenia as a disorder of developmentally reduced synaptic connectivity

1 reference

12 December 2020

The current status of the dopamine hypothesis of schizophrenia

1 reference

12 December 2020

Erythropoietin receptor is expressed in rat hippocampal and cerebral cortical neurons, and erythropoietin prevents in vitro glutamate-induced neuronal death

1 reference

12 December 2020

Erythropoietin receptor-mediated inhibition of exocytotic glutamate release confers neuroprotection during chemical ischemia

1 reference

12 December 2020

Erythropoietin administration protects retinal neurons from acute ischemia-reperfusion injury.

1 reference

12 December 2020

Survival of hippocampal neurons in culture upon hypoxia

1 reference

12 December 2020

Traumatic brain injury and schizophrenia in members of schizophrenia and bipolar disorder pedigrees.

1 reference

12 December 2020

Normobaric hypoxia induces tolerance to focal permanent cerebral ischemia in association with an increased expression of hypoxia-inducible factor-1 and its target genes, erythropoietin and VEGF, in the adult mouse brain.

1 reference

12 December 2020

Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-kappaB signalling cascades

1 reference

12 December 2020

Mapping adolescent brain change reveals dynamic wave of accelerated gray matter loss in very early-onset schizophrenia

1 reference

12 December 2020

Hypoxia-induced stroke tolerance in the mouse is mediated by erythropoietin.

1 reference

12 December 2020

Inactivation of erythropoietin leads to defects in cardiac morphogenesis

1 reference

12 December 2020

Effects of erythropoietin on neuronal activity.

1 reference

12 December 2020

Erythropoietin exerts neuroprotection in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated C57/BL mice via increasing nitric oxide production

1 reference

12 December 2020

Hearts from rodents exposed to intermittent hypoxia or erythropoietin are protected against ischemia-reperfusion injury.

1 reference

12 December 2020

Erythropoietin protects cardiac myocytes from hypoxia-induced apoptosis through an Akt-dependent pathway.

1 reference

12 December 2020

In vivo evidence that erythropoietin protects neurons from ischemic damage

1 reference

12 December 2020

Erythropoietin and erythropoietin receptor in human ischemic/hypoxic brain.

1 reference

12 December 2020

The changing roles and targets for animal models of schizophrenia

1 reference

12 December 2020

Recombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodeling

1 reference

12 December 2020

Erythropoietin prevents early and late neuronal demise through modulation of Akt1 and induction of caspase 1, 3, and 8.

1 reference

12 December 2020

Intelligence quotient and neuropsychological profiles in patients with schizophrenia and in normal volunteers

1 reference

12 December 2020

Neuronal replacement from endogenous precursors in the adult brain after stroke

1 reference

12 December 2020

Clinical trials with neuroprotective drugs in acute ischaemic stroke: are we doing the right thing?

1 reference

12 December 2020

In vitro development of primitive and definitive erythrocytes from different precursors

1 reference

12 December 2020

A novel protective effect of erythropoietin in the infarcted heart

1 reference

12 December 2020

Erythropoietin and erythropoietin receptors in the peripheral nervous system: changes after nerve injury

1 reference

12 December 2020

The neurodevelopmental hypothesis of schizophrenia: following a trail of evidence from cradle to grave

1 reference

12 December 2020

Erythropoietin regulates the in vitro and in vivo production of neuronal progenitors by mammalian forebrain neural stem cells.

1 reference

12 December 2020

Erythropoietin therapy for acute stroke is both safe and beneficial

1 reference

12 December 2020

Erythropoietin receptor signalling is required for normal brain development

1 reference

12 December 2020

Functional neurogenesis in the adult hippocampus

1 reference

12 December 2020

Erythropoietin selectively attenuates cytokine production and inflammation in cerebral ischemia by targeting neuronal apoptosis

1 reference

12 December 2020

Erythropoietin prevents motor neuron apoptosis and neurologic disability in experimental spinal cord ischemic injury

1 reference

12 December 2020

Erythropoietin is a paracrine mediator of ischemic tolerance in the brain: evidence from an in vitro model

1 reference

12 December 2020

Neuroprotection--what does it mean?--What means do we have?

1 reference

12 December 2020

Asialoerythropoietin is a nonerythropoietic cytokine with broad neuroprotective activity in vivo.

1 reference

12 December 2020

Induction of neurogenesis in the neocortex of adult mice

1 reference

12 December 2020

Epidemiology of schizophrenia. A thriving discipline at the turn of the century

1 reference

12 December 2020

Neurogenesis in the adult human hippocampus

1 reference

12 December 2020

Use of recombinant human erythropoietin as an antianemic and performance enhancing drug

1 reference

12 December 2020

Erythropoietin--a novel concept for neuroprotection

1 reference

12 December 2020

Erythropoietin exerts an anti-inflammatory effect on the CNS in a model of experimental autoimmune encephalomyelitis.

1 reference

12 December 2020

Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury

1 reference

12 December 2020

HIF-1-induced erythropoietin in the hypoxic retina protects against light-induced retinal degeneration

1 reference

12 December 2020

Erythropoietin: a candidate compound for neuroprotection in schizophrenia

1 reference

12 December 2020

A potential role for erythropoietin in focal permanent cerebral ischemia in mice.

1 reference

12 December 2020

10.1023/B:MEBR.0000043969.96895.3C

Identifiers

DOI

1 reference

Dimensions Publication ID

11 August 2017

0 references

1 reference